COX-2 inhibition: a possible role in the management of prostate cancer?

Sooriakumaran, P; Langley, S E M; Laing, R W; Coley, H M

Sooriakumaran, P; Langley, S E M; Laing, R W; Coley, H M.

Affiliation

Sooriakumaran P; Royal Surrey County Hospital, UK. sooriakumaran@gmail.com

J Chemother ; 19(1): 21-32, 2007 Feb.

Article in En | MEDLINE | ID: mdl-17309847

Subject(s)

Cyclooxygenase Inhibitors/therapeutic use; Prostatic Neoplasms/drug therapy; Anti-Inflammatory Agents, Non-Steroidal/therapeutic use; Apoptosis; Clinical Trials as Topic; Cyclooxygenase 2/physiology; Cyclooxygenase Inhibitors/adverse effects; Humans; Male; Neovascularization, Pathologic/enzymology; Oxidative Stress; Prostatic Neoplasms/blood supply; Prostatic Neoplasms/enzymology

Search on Google

XML

PubMed Links

Collection: 01-internacional Database: MEDLINE Main subject: Prostatic Neoplasms / Cyclooxygenase Inhibitors Type of study: Systematic_reviews Limits: Humans / Male Language: En Journal: J Chemother Journal subject: ANTINEOPLASICOS / TERAPIA POR MEDICAMENTOS Year: 2007 Type: Article Affiliation country: United kingdom

Search on Google

XML

PubMed Links